Subject(s)
Neuroleptic Malignant Syndrome/diagnosis , Serotonin Syndrome/diagnosis , Adult , Clozapine/adverse effects , Cyclohexanols/adverse effects , Fluoxetine/adverse effects , Humans , Male , Serotonin Antagonists/adverse effects , Selective Serotonin Reuptake Inhibitors/adverse effects , Venlafaxine HydrochlorideABSTRACT
A 73 years old woman without cardiovascular risk factors presented physical exercise angina and dyspnea since 8 months ago. The caused of the disease was a left atrial myxoma which entering in left ventricle. The patient was free of coronary injured.
Subject(s)
Angina Pectoris/etiology , Heart Neoplasms/complications , Myxoma/complications , Aged , Angina Pectoris/diagnosis , Angina Pectoris/surgery , Cardiac Surgical Procedures , Echocardiography , Female , Heart Atria/pathology , Heart Atria/surgery , Heart Neoplasms/pathology , Heart Neoplasms/surgery , Humans , Myxoma/pathology , Myxoma/surgery , Treatment OutcomeABSTRACT
We present a case report of a Latin-American patient with dilated cardiomyopathy due to chronic Chagas disease satisfactorily treated with usual cardiologic support. We report a new aetiology of heart failure which is uncommon in our country but could rise due to immigration from endemic countries.
Subject(s)
Cardiomyopathy, Dilated/parasitology , Chagas Cardiomyopathy/diagnosis , Humans , Male , Middle AgedABSTRACT
PML affects 4% of patients with AIDS and there is no effective treatment. Five cases of PML-AIDS have been described, showing clinical and radiological improvement after treatment with C-ara. We describe the case of a 33-year-old woman, addict to heroin, her clinical record including VIH infection, pneumonia by P. carinii, milliary tuberculosis, infection by virus B and C and treatment with AZT and tuberculostatics since January, 1992. In May, she began to develop a cerebellar syndrome. Images obtained with nuclear magnetic resonance were typical of PML. Subsequently, treatment with C-ara (2 mg/kg/day IV during 5 days each 4-6 weeks) was begun. From the third month of treatment on, the patient showed a clinical improvement and as of the sixth month, the affected areas of white substance were reduced in size. In addition, CD4 improved. Although in this patient a positive effect was observed after treatment with C-area, it should be verified in a controlled clinical trial.
